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Use of minor tranquillisers in intentional overdose  
Drug overdose is the most common method of self harm in Ireland, 
which is involved in 77% of all self-harm acts registered by the 
National Registry of Deliberate Self Harm (NRDSH) in 2010 and 
more so in women (77%) than in men (65%). Since the start of the 
Registry, minor tranquillisers (benzodiazepines) are the most 
common drug involved in intentional overdose representing 29% (ca. 
3,500) of self harm episodes presenting to hospital Emergency 
Departments each year.    
Investigating trends in the use of minor tranquillisers in intentional 
overdose over time, the 5 most frequently used minor tranquilisers 
are Diazepam, Dalmane, Xanax, Stilnoct and Zimovane, with 
Diazepam being most common. 
Between 2003 and 2006 an increasing trend was observed for the 
use of diazepam which has stabilised in recent years. Since 2006, 
there has been a decreasing trend in the use of Dalmane and a 
slightly increasing trend in the use of Xanax and Stilnoct. A stable 
pattern over time was observed for the use of Zimovane in intentional 
overdose. 
 
Prevalence of minor tranquillisers by geographical region 
There is considerable variation in the use of minor tranquillisers 
involved in intentional overdose by Hospital group area (Figure 1).  
 
Figure 1 Intentional overdose involving minor tranquillisers by 
hospital group (average percentage 2003-2010) 
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In all areas other than the North Eastern area and Mid-Western 
area, Diazepam is the most frequently used drugs in intentional 
overdose. Use of Xanax is particularly high (26%) in both the 
North Eastern and Mid-Western areas. The use of Zimovane is 
relatively high in the Dublin areas (18%), Mid-Western (14%) and 
West/North Western area (13%). 
 
Effectiveness of the DUMP project in reducing use of 
minor tranquillisers in intentional overdose  
The campaign to Dispose of Unused Medications Properly 
(DUMP) was launched in 2002 (O’Driscoll et al, 2009). It aims to 
encourage people to return their unused medicines to their local 
community pharmacies. One hundred and fifty seven 
pharmacies have been involved in the full roll out of the DUMP 
project in the former South Western Area Health Board 
(SWAHB), since 2002.  
During the period 2004-2010, use of minor tranquillisers involved 
in intentional overdose in the former SWHAB area remained 
stable, with a slight decrease in 2010 (Figure 2). However, in the 
rest of the country an increasing trend has been observed since 
2007. These findings support the effectiveness of the DUMP 
project on reducing intentional overdose involving minor 
tranquillisers.  
 
Figure 2 Effects of the DUMP project on the use of minor 
tranquillisers in intentional overdose (Former South Western 
Area Health Board Region, 2004-2010) 
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These findings are consistent with various other national and 
international initiatives aimed at restricting access to frequently 
used means in self-harm and suicide (Sarchiapone et al, 2011; 
Corcoran et al, 2010; Mann et al, 2005). 
 
In January 2012, the National Office for Suicide Prevention 
established a National Working Group to Restrict Access to 
Means, with a central focus on reducing access to minor 
tranquillisers. Objectives of the Working Group are to promote 
the safe storage and disposal of medications and increase 
awareness among prescribers and the general public. Taking 
into account the evidence supporting the effectiveness of the 
DUMP project in the former SWAB area, the Working Group 
would strongly recommend implementation of the DUMP 
campaign at national level.   
The Incidence and Repetition of Hospital-Treated 
Deliberate Self Harm: Findings from the World's First 
National Registry 
 
Few countries worldwide have reliable data on deliberate self-harm 
(DSH). There is a broad spectrum of self harming behaviours ranging 
from deliberate recklessness to highly lethal attempts at suicide and 
only a minority of adolescents and adults who self-harm present to 
hospital. 
We have established a national DSH registry in the Republic of 
Ireland. The purpose of this national registry is to determine and 
monitor the incidence and repetition of DSH, to identify high-
incidence groups and areas and to inform services and practitioners 
concerned with the prevention of suicidal behaviour.  
Between 2003 and 2009, the Irish National Registry of Deliberate 
Self Harm (NRDSH) collected data on DSH presentations to all 40 
hospital emergency departments in Ireland. Data was collected by 
trained data registration officers using standard methods of case 
ascertainment and definition. The Registry recorded 75,119 DSH 
presentations involving 48,206 individuals. The total incidence rate 
fell from 209 per 100,000 in 2003 to 184 per 100,000 in 2006 and 
increased again to 209 per 100,000 in 2009. The most notable 
annual changes were successive 10% increases in the male rate in 
2008 and 2009. There was significant variation by age with peak 
rates in women in the 15–19 year age group (620 per 100,000), and 
in men in the 20–24 age group (427 per 100,000). Repetition rates 
varied significantly by age, method of self harm and number of 
previous episodes. 
Of the 48,206 people who made the 75,119 DSH presentations to 
hospital in 2003-2009, 10,516 (22%) repeated at least once, 4,642 
(10%) repeated at least twice and 453 (1%) repeated at least nine 
times. This group of 453 frequent repeaters accounted for 8,080 
(11%) of the 75,119 self harm presentations over the seven years of 
observation. 
Acts involving self-cutting were associated with an elevated risk of 
repetition for both genders but where cutting was the sole method of 
DSH the increased risk of repetition among women was higher than 
that among men.   
Population-based data on hospital-treated DSH represent an 
important index of the burden of mental illness and suicide risk in the 
community. The increased DSH rate in Irish men in 2008 and 2009 
coincided with the advent of the economic recession in Ireland. The 
findings underline the need for developing effective interventions to 
reduce DSH repetition rates as a key priority for health systems. 
 
Reference: Perry IJ, Corcoran P, Fitzgerald AP, Keeley HS, Reulbach U, 
Arensman E (2012) The Incidence and Repetition of Hospital-Treated 
Deliberate Self Harm: Findings from the World’s First National Registry. PLoS 
ONE 7 (2): e31663. doi:10.1371. 
 
 
Clinicopathological significance of psychotic experiences 
in non-psychotic young people: evidence from four 
population-based studies 
 
Research has shown that hallucinations and delusions, the classic 
symptoms of psychosis, are far more prevalent in the population than 
actual psychotic disorder. These symptoms are especially prevalent 
in childhood and adolescence. Longitudinal research has 
demonstrated that psychotic symptoms in adolescence increase the 
risk of psychotic disorder in adulthood. There has been a lack of 
research on the immediate clinicopathological significance of 
psychotic symptoms in adolescence. 
This study aimed to investigate the relationship between psychotic 
symptoms and non-psychotic psychopathology in community 
samples of adolescents in terms of prevalence, co-occurring 
disorders, multiple psychopathology and variation across early 
versus middle adolescence. 
Data from four population studies were used: two early adolescence 
studies (ages 11-13 years) and two mid-adolescence studies (ages 
13-16 years). Studies 1 and 2 involved school-based surveys of 
2,243 children aged 11-16 years and looked at psychotic symptoms 
and emotional and behavioural symptoms of psychopathology.  
The mid-adolescent studies involved in-depth diagnostic 
interview assessments of psychotic symptoms and lifetime 
psychiatric disorders in community samples of 423 children aged 
11-15 years.  
This study found that younger adolescents had a higher 
prevalence (21-23%) of psychotic symptoms than older 
adolescents (7%). In both age groups the majority of adolescents 
who reported psychotic symptoms had at least one diagnosable 
non-psychotic psychiatric disorder, although associations with 
psychopathology increased with age. Nearly 80% of the mid-
adolescence sample who reported psychotic symptoms had at 
least one diagnosis, compared with 57% of the early 
adolescence sample. Adolescents who reported psychotic 
symptoms were at particularly high risk of having multiple co-
occurring diagnoses. 
Psychotic symptoms are important risk markers for a wide range 
of non-psychotic psychopathological disorders, in particular for 
severe psychopathology characterised by multiple co-occurring 
diagnoses. These symptoms should be carefully assessed in all 
patients. 
 
Reference:  Kelleher I, Keeley H, Corcoran P, Lynch F, Fitzpatrick C, 
Devlin N, Molloy C, Roddy S, Clarke MC, Harley M, Arseneault L, 
Wasserman C, Carli V, Sarchiapone M, Hoven C, Wasserman D, 
Cannon M (2012). Clinicopathological significance of psychotic 
experiences in non-psychotic young people: evidence from four 
population-based studies. British Journal of Psychiatry, Apr 12. [Epub 
ahead of print] DOI: 10.1192. 
 
Non-Suicidal Self-Injury – Is there a case for a new 
diagnostic category? 
 
In the US, preparations are underway for the next edition of the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-5) 
which will be published in 2013. One of the newly proposed 
diagnostic categories for inclusion is Non-Suicidal Self Injury 
(NSSI). Non-Suicidal Self Injury refers to intentional destruction 
of one’s own body tissue (e.g. cutting, burning, hitting) without 
suicidal intent and for purposes not socially sanctioned.  
Concerns have been reported in relation to the proposal to 
include a diagnostic category for NSSI due to lack of sufficient 
evidence and potential negative implications for assessment, 
treatment and prevention. 
The need to improve assessment procedures to determine the 
degree of suicidal intent among people engaging in self-harm 
has been highlighted as a key priority rather than the need to 
distinguish between those with and without suicidal intent. This 
view is further supported by evidence that suicidal intent is a fluid 
rather than a dichotomous concept. This raises the question 
about the validity and clinical relevance of classifying self-harm 
patients into ‘yes/no suicidal categories’.  
Evidence has been reported for subgroups of self-harm patients 
characterised by mild versus those with severe self-harm 
representing the opposite poles of a dimensional concept of 
severity. Low severity was associated with low (not “zero”) 
suicidal intent, low degree (not “absence”) of suicidal 
preoccupation, low lethal self-harm methods, trying to influence 
someone and wish to seek help. 
Considering that NSSI was found to be significantly associated 
with attempted suicide and suicide, a diagnosis of NSSI could 
prevent the identification of a significant group of people who are 
at risk for further suicide attempts and who could benefit from 
targeted interventions.  
While at present the evidence would not support NSSI as a 
separate diagnostic category, it may have a useful place as a 
subtype of self-harm at an individual clinical level. 
 
Reference: Arensman E, Keeley HS (2012). Non-Suicidal Self-Injury – Is 
there a case for a new diagnostic category? Psychiatry Professional, 
Spring. 
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